Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer

By Stephenson A.J.   Aprikian A.G.   Souhami L.   Behlouli H.   Jacobson A.I.   Begin L.R.   Tanguay S.  

Urology, Vol. 59, Iss. 5, 2002-05 ,pp. : 652-656

Elsevier

Access to resources Recommend Favorite

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

By Yoon J.H.   Chen M.-H.   Renshaw A.A.   Richie J.P.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 454-457

Elsevier

Access to resources Recommend Favorite

Can Expression of Apoptosis Genes, bcl-2 and bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?

By Kymionis G.D.   Dimitrakakis C.E.   Konstadoulakis M.M.   Arzimanoglou I.   Leandros E.   Chalkiadakis G.   Keramopoulos A.   Michalas S.  

Journal of Surgical Research, Vol. 99, Iss. 2, 2001-08 ,pp. : 161-168

Academic Press

Access to resources Recommend Favorite

Prostate cancer detection: relationship to prostate size - predictive value for cancer

By Chen M.E.   Troncoso P.   Johnston D.   Tang K.   Babaian R.J.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 764-768

Elsevier

Access to resources Recommend Favorite

Predictive Value of Prostate-specific Antigen, Tumour Stage and Tumour Grade for the Outcome of Bone Scintigraphy in Patients with Newly Diagnosed Prostate Cancer

By Rydh Anders   Tomic Radisa   Tavelin Björn   Hietala Sven-Ola   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 2, 1999-08 ,pp. : 89-93

Informa Healthcare

Access to resources Recommend Favorite